A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms

Lisa Hanson; Leona VandeVusse; Marie M Forgie; Emily Malloy; Maharaj Singh; MaryAnne Scherer; Diana Kleber; Jonah Dixon; Andrew Andrew Hryckowian; Nasia Safdar; Aurora Midwifery Faculty; Aurora Ob/Gyn Faculty; Andrew J Hryckowian

doi:10.1016/j.ajogmf.2022.100748

A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms

Lisa Hanson, Leona VandeVusse, Marie M Forgie, Emily Malloy, Maharaj Singh, MaryAnne Scherer, Diana Kleber, Jonah Dixon, Andrew Andrew Hryckowian, Nasia Safdar, Aurora Midwifery Faculty, Aurora Ob/Gyn Faculty, Andrew J Hryckowian

Advocate Aurora Health

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	American Journal of Obstetrics & Gynecology MFM
DOIs	https://doi.org/10.1016/j.ajogmf.2022.100748
Status	Published - Jan 1 2023

Keywords

Antenatal
Gastrointestinal symptoms
Group B Streptococcus
Probiotics

Access to Document

10.1016/j.ajogmf.2022.100748License: Unspecified

https://libkey.io/libraries/1712/10.1016/j.ajogmf.2022.100748

Cite this

Hanson, L., VandeVusse, L., Forgie, M. M., Malloy, E., Singh, M., Scherer, M., Kleber, D., Dixon, J., Hryckowian, A. A., Safdar, N., Midwifery Faculty, A., Ob/Gyn Faculty, A., & Hryckowian, A. J. (2023). A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms. American Journal of Obstetrics & Gynecology MFM. https://doi.org/10.1016/j.ajogmf.2022.100748

Hanson, L, VandeVusse, L, Forgie, MM , Malloy, E, Singh, M, Scherer, M, Kleber, D, Dixon, J, Hryckowian, AA, Safdar, N, Midwifery Faculty, A, Ob/Gyn Faculty, A & Hryckowian, AJ 2023, 'A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms', American Journal of Obstetrics & Gynecology MFM. https://doi.org/10.1016/j.ajogmf.2022.100748

@article{795b968179694d208f17825a2ea18659,

title = "A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms",

keywords = "Antenatal, Gastrointestinal symptoms, Group B Streptococcus, Probiotics",

author = "Lisa Hanson and Leona VandeVusse and Forgie, {Marie M} and Emily Malloy and Maharaj Singh and MaryAnne Scherer and Diana Kleber and Jonah Dixon and Hryckowian, {Andrew Andrew} and Nasia Safdar and {Midwifery Faculty}, Aurora and {Ob/Gyn Faculty}, Aurora and Hryckowian, {Andrew J}",

note = "Hanson L, VandeVusse L, Forgie M, et al. A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms. Am J Obstet Gynecol MFM. 2023;5(1):100748. doi:10.1016/j.ajogmf.2022.100748",

year = "2023",

month = jan,

day = "1",

doi = "10.1016/j.ajogmf.2022.100748",

language = "American English",

journal = "American Journal of Obstetrics & Gynecology MFM",

}

TY - JOUR

T1 - A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms

AU - Hanson, Lisa

AU - VandeVusse, Leona

AU - Forgie, Marie M

AU - Malloy, Emily

AU - Singh, Maharaj

AU - Scherer, MaryAnne

AU - Kleber, Diana

AU - Dixon, Jonah

AU - Hryckowian, Andrew Andrew

AU - Safdar, Nasia

AU - Midwifery Faculty, Aurora

AU - Ob/Gyn Faculty, Aurora

AU - Hryckowian, Andrew J

N1 - Hanson L, VandeVusse L, Forgie M, et al. A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms. Am J Obstet Gynecol MFM. 2023;5(1):100748. doi:10.1016/j.ajogmf.2022.100748

PY - 2023/1/1

Y1 - 2023/1/1

KW - Antenatal

KW - Gastrointestinal symptoms

KW - Group B Streptococcus

KW - Probiotics

UR - https://institutionalrepository.aah.org/auroragme/159

UR - https://libkey.io/libraries/1712/10.1016/j.ajogmf.2022.100748

UR - https://institutionalrepository.aah.org/auroragme/305

U2 - 10.1016/j.ajogmf.2022.100748

DO - 10.1016/j.ajogmf.2022.100748

M3 - Article

C2 - 36108911

JO - American Journal of Obstetrics & Gynecology MFM

JF - American Journal of Obstetrics & Gynecology MFM

ER -

A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms

Keywords

Access to Document

Other files and links

Cite this